memantine and Disease Models, Animal

Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus

Topics: Alzheimer Disease; Animals; Cholinesterase Inhibitors; Data Mining; Databases, Factual; Disease Models, Animal; Donepezil; Drug Evaluation, Preclinical; Exercise Therapy; Humans; Indans; Memantine; Piperidines; Species Specificity; Systems Biology; Systems Integration; Translational Research, Biomedical

Topics: Alzheimer Disease; Animals; Dementia; Disease Models, Animal; Donepezil; Humans; Indans; Memantine; Methylene Blue; Piperidines; Rodentia; Species Specificity; Zebrafish

Topics: Animals; Clinical Trials as Topic; Disease Models, Animal; Endpoint Determination; Excitatory Amino Acid Antagonists; Glaucoma, Open-Angle; Humans; Memantine; N-Methylaspartate; Nervous System Diseases; Neuroprotective Agents; Optic Nerve Diseases; Riluzole

Topics: Animals; Catechin; Chromosomes, Human, Pair 21; Disease Models, Animal; Down Syndrome; Droxidopa; Drug Delivery Systems; Fluoxetine; Forecasting; Gene Expression Regulation; Genetic Association Studies; Genetic Therapy; Hedgehog Proteins; Humans; Memantine; Mice; Mice, Transgenic; Models, Genetic; Neuronal Plasticity; Neurotransmitter Agents; Pentylenetetrazole; Phenotype; Signal Transduction

Topics: Aging; Alzheimer Disease; Animals; Cholinesterase Inhibitors; Disease Models, Animal; Histamine H3 Antagonists; Humans; Ligands; Memantine; Memory Disorders; Nootropic Agents; Phosphodiesterase Inhibitors; Receptors, Muscarinic; Receptors, Nicotinic; Receptors, Serotonin; Translational Research, Biomedical

Topics: Animals; Cognition Disorders; Disease Models, Animal; Down Syndrome; Excitatory Amino Acid Antagonists; Humans; Memantine; Nerve Degeneration; Randomized Controlled Trials as Topic; Translational Research, Biomedical

Topics: Amantadine; Animals; Disease Models, Animal; Excitatory Amino Acid Antagonists; Humans; Ketamine; Memantine; Neuralgia

Topics: Animals; Clinical Trials as Topic; Dextromethorphan; Disease Models, Animal; Excitatory Amino Acid Antagonists; Humans; Memantine; Neuralgia; Receptors, N-Methyl-D-Aspartate

Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Humans; Memantine; Mice; Mice, Transgenic; Neurites; Neurotransmitter Agents; Receptors, N-Methyl-D-Aspartate; Synapses

Topics: Aged; Alzheimer Disease; Animals; Antipsychotic Agents; Caregivers; Case Management; Cholinesterase Inhibitors; Disease Models, Animal; Donepezil; Dopamine Agents; Excitatory Amino Acid Antagonists; Follow-Up Studies; Forecasting; Health Education; Humans; Indans; Memantine; Mental Disorders; Meta-Analysis as Topic; Nootropic Agents; Occupational Therapy; Piperidines; Practice Guidelines as Topic; Psychotropic Drugs; Randomized Controlled Trials as Topic; Time Factors

Topics: Animals; Brain; Disease Models, Animal; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Humans; Learning; Memantine; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate

Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus

Topics: Animals; Behavior, Animal; Cerebral Cortex; Cerebral Infarction; Disease Models, Animal; Excitatory Amino Acid Antagonists; Memantine; Mice; Mice, Inbred C57BL; Random Allocation; Recovery of Function; Single-Blind Method; Stroke

Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Memantine; Mice; Molecular Structure; Polyamines; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship; Thrombosis

Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries

Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Behavior, Animal; Binding Sites; Cell Survival; Coumarins; Disease Models, Animal; Drug Design; Humans; Iron Chelating Agents; Mice; Mice, Inbred ICR; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; PC12 Cells; Peptide Fragments; Rats; Structure-Activity Relationship

Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

Topics: Alzheimer Disease; Animals; Caenorhabditis elegans; Disease Models, Animal; Memantine; Mice; Receptors, N-Methyl-D-Aspartate

Topics: Animals; Antidepressive Agents; Astrocytes; Behavior, Animal; Calpain; Depression; Disease Models, Animal; Excitatory Amino Acid Antagonists; Hippocampus; Inflammasomes; Lipopolysaccharides; Male; Memantine; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphorylation; Potassium Channels, Inwardly Rectifying; Receptors, N-Methyl-D-Aspartate; Signal Transduction

Topics: Angiogenesis Inducing Agents; Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Graft Survival; Inflammation Mediators; Lipid Peroxidation; Male; Memantine; Neovascularization, Physiologic; Oxidative Stress; Rats, Sprague-Dawley; Reperfusion Injury; Skin; Skin Transplantation; Surgical Flaps; Up-Regulation; Vascular Endothelial Growth Factor A

Topics: Alzheimer Disease; Animals; Disease Models, Animal; Gait Analysis; Male; Memantine; Mice; Mice, Transgenic; Vitamin D; Vitamin D Deficiency

Topics: Animals; Compulsive Behavior; Disease Models, Animal; Dopamine Agonists; Memantine; Obsessive-Compulsive Disorder; Quinpirole; Rats; Rats, Long-Evans; Rats, Sprague-Dawley

Topics: Adenosine Triphosphate; Alzheimer Disease; Animals; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cognition; Disease Models, Animal; Memantine; Mice; Mice, Transgenic; Propolis

Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Disease Models, Animal; Humans; Hypercapnia; Hypoxia; Memantine; Mice; Mice, Transgenic; Quality of Life; Respiration; Rivastigmine

Topics: Adolescent; Animals; Disease Models, Animal; Dual-Specificity Phosphatases; Humans; Lafora Disease; Memantine; Mice; Mice, Knockout; Minocycline; Myoclonic Epilepsies, Progressive; Protein Tyrosine Phosphatases, Non-Receptor; Resveratrol; Ubiquitin-Protein Ligases

Topics: Alzheimer Disease; Animals; Arginase; Brain-Derived Neurotrophic Factor; Calcineurin; Calcium; Chitinases; Cytokines; Disease Models, Animal; Glial Fibrillary Acidic Protein; Memantine; Mice; Microglia; Nerve Growth Factor; NF-kappa B; Oxidative Stress; Receptors, N-Methyl-D-Aspartate

Topics: Animals; Disease Models, Animal; Female; Injections, Intraperitoneal; Interleukin-6; Memantine; Mice; Mice, Inbred BALB C

Topics: Animals; Aripiprazole; Autism Spectrum Disorder; Autistic Disorder; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Disease Models, Animal; Female; gamma-Aminobutyric Acid; Glutamates; Hippocampus; Homeostasis; Male; Memantine; Pregnancy; Rats; Rats, Wistar; Valproic Acid

Topics: Alzheimer Disease; Animals; Antioxidants; Disease Models, Animal; Donepezil; Edaravone; Inflammation; Male; Maze Learning; Memantine; Memory Disorders; Mice; Oxidative Stress; Rats; Rats, Wistar; Streptozocin

Topics: Alzheimer Disease; Animals; Disease Models, Animal; Hippocampus; Male; Maze Learning; Memantine; Neurodegenerative Diseases; Rats; Streptozocin

Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Cholinesterase Inhibitors; Disease Models, Animal; Drug Combinations; Female; Male; Maze Learning; Melatonin; Memantine; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Peptide Fragments

Topics: Aluminum Chloride; Alzheimer Disease; Animals; Brain; Cognition; Dendrimers; Disease Models, Animal; Dopamine; Drug Carriers; Drug Liberation; Erythrocytes; Lactoferrin; Memantine; Mice; Rats; Tissue Distribution

Topics: Acetic Acid; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antiparkinson Agents; Brain; Chitosan; Disease Models, Animal; Drug Compounding; Drug Liberation; Gamma Rays; Humans; Interleukins; Male; Memantine; Morris Water Maze Test; Nanocapsules; Rats; Solubility; Tumor Necrosis Factor-alpha; Water

Topics: Alzheimer Disease; Animals; Animals, Genetically Modified; Biomarkers; Choline; Cognitive Dysfunction; Dietary Supplements; Disease Models, Animal; Gastrointestinal Microbiome; Lactobacillus plantarum; Male; Memantine; Metagenomics; Mice; Probiotics; Pyramidal Cells

Topics: Administration, Oral; Alzheimer Disease; Animals; Disease Models, Animal; Electromyography; Excitatory Amino Acid Antagonists; Female; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Memantine; Stomach; Sus scrofa

Topics: Allosteric Regulation; alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Animals; Cholinergic Antagonists; Cholinesterase Inhibitors; Disease Models, Animal; Donepezil; Drug Synergism; Excitatory Amino Acid Antagonists; Galantamine; Isoxazoles; Memantine; Nootropic Agents; Phenylurea Compounds; Rats; Recognition, Psychology; Scopolamine

Topics: Animals; Behavior, Animal; Body Weight; Diet; Disease Models, Animal; Eating; Feeding and Eating Disorders; Food Addiction; Hippocampus; Male; Memantine; Memory; Memory Disorders; Neurogenesis; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate

Topics: Animals; Dextromethorphan; Disease Models, Animal; Epilepsy, Generalized; Excitatory Amino Acid Antagonists; Gene Knock-In Techniques; Humans; Infant; Male; Memantine; Mice; Neurodevelopmental Disorders; Receptors, N-Methyl-D-Aspartate

Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Antiparkinson Agents; Aspartic Acid Endopeptidases; Biomarkers; Brain; Disease Models, Animal; Gene Expression; Hippocampus; Male; Maze Learning; Memantine; Random Allocation; Rats; Rats, Wistar; RNA, Long Noncoding; Streptozocin

Topics: Animals; Apoptosis; Aquaporin 4; Disease Models, Animal; Excitatory Amino Acid Antagonists; Female; Humans; Immunoglobulin G; Memantine; Mice; Motor Disorders; Neuromyelitis Optica; Receptors, N-Methyl-D-Aspartate; Spinal Cord

Topics: Animals; Anticonvulsants; Brain; Cell Death; Dexmedetomidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electroencephalography; Isoflurophate; Male; Memantine; Neurons; Phenobarbital; Prohibitins; Rats; Rats, Sprague-Dawley; Status Epilepticus; Time-to-Treatment; Treatment Outcome

Topics: Administration, Oral; Alzheimer Disease; Animals; Anxiety; Behavior, Animal; CA1 Region, Hippocampal; Disease Models, Animal; Memantine; Mice, Transgenic; Motor Activity; Neurogenesis; Neurons; Open Field Test; Spatial Memory

Topics: Animals; Conditioning, Classical; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking Behavior; Eating; Feeding Behavior; Humans; Memantine; Memory; Rats; Receptors, N-Methyl-D-Aspartate

Topics: Alzheimer Disease; Amnesia; Amyloid beta-Peptides; Animals; Behavior, Animal; Disease Models, Animal; Male; Memantine; Memory Disorders; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Peptide Fragments

Topics: Animals; Anti-Inflammatory Agents; Astrocytes; Calcium; Calcium Signaling; Cell Line, Tumor; Disease Models, Animal; Excitatory Amino Acid Antagonists; Ibuprofen; Inflammation; Memantine; Rats; Receptors, N-Methyl-D-Aspartate; Streptozocin

Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Disease Models, Animal; Drug Screening Assays, Antitumor; Female; Glutamic Acid; Memantine; Mice; Mice, Inbred BALB C; Tumor Cells, Cultured

Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Autophagy; Autophagy-Related Protein-1 Homolog; Avoidance Learning; Cognition Disorders; Disease Models, Animal; Donepezil; Drug Evaluation, Preclinical; Hydrazones; MAP Kinase Signaling System; Memantine; Mice; Mice, Transgenic; Morris Water Maze Test; Neuroprotective Agents; Phosphorylation; Protein Processing, Post-Translational; Pyrazines; Random Allocation; Recognition, Psychology; Signal Transduction; tau Proteins; TOR Serine-Threonine Kinases

Topics: Altitude; Altitude Sickness; Alzheimer Disease; Animals; Cell Death; Cognition; Cognitive Dysfunction; Disease Models, Animal; Excitatory Amino Acid Antagonists; Glutamic Acid; Hippocampus; Hypoxia; Male; Memantine; Memory; Neurons; Neuroprotective Agents; Neurotoxins; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate

Topics: Animals; Disease Models, Animal; Electroencephalography; Male; Memantine; Pentylenetetrazole; Rats; Rats, Wistar; Seizures

Topics: Animals; Blood-Brain Barrier; Brain Edema; Cerebral Hemorrhage; Collagenases; Disease Models, Animal; Gelatinases; Inflammasomes; Interleukin-1beta; Matrix Metalloproteinase 9; Memantine; Neuroprotective Agents; Nitric Oxide Synthase Type I; NLR Family, Pyrin Domain-Containing 3 Protein; Peroxynitrous Acid; Phosphorylation; Rats

Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Body Composition; Dietary Supplements; Disease Models, Animal; Dopamine Agents; Male; Memantine; Mice; Mice, Transgenic; Presenilin-1; Vitamin D; Vitamin D Deficiency

Topics: Alzheimer Disease; Animals; Disease Models, Animal; Memantine; Mice; Mice, Transgenic

Topics: Administration, Oral; Alzheimer Disease; Animals; Disease Models, Animal; Dizziness; Drug Therapy, Combination; Drugs, Chinese Herbal; Male; Memantine; Memory Disorders; Mice, Inbred Strains; Phytotherapy; Receptors, N-Methyl-D-Aspartate

Topics: Animals; Binding Sites; Catalytic Domain; Disease Models, Animal; Drug Design; Enzyme Inhibitors; Epoxide Hydrolases; Female; Humans; Lipopolysaccharides; Male; Memantine; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Rats; Sepsis; Structure-Activity Relationship; Survival Rate; Urea

Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Disease Models, Animal; Male; Memantine; Memory; Obsessive-Compulsive Disorder; Rats; Rats, Long-Evans; Riluzole; Spatial Learning

Topics: Animals; Disease Models, Animal; Dopamine Agents; Memantine; Mice; Neurodegenerative Diseases; Neuroglia; Optogenetics; Protective Agents; Purkinje Cells

Topics: Animals; Behavior, Animal; Brain Concussion; Cerebral Cortex; Disease Models, Animal; Excitatory Amino Acid Antagonists; Hippocampus; Male; Memantine; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; Random Allocation; Receptors, N-Methyl-D-Aspartate; Tissue Culture Techniques

Topics: Alzheimer Disease; Animals; Cognition; Disease Models, Animal; Donepezil; Indans; Levetiracetam; Male; Maze Learning; Memantine; Memory; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nootropic Agents; Piperidines; Piracetam; Recognition, Psychology

Topics: Administration, Oral; Animals; Brain; Disease Models, Animal; Down Syndrome; Excitatory Amino Acid Antagonists; Female; Gas Chromatography-Mass Spectrometry; Injections, Intraperitoneal; Liver; Male; Memantine; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Tissue Distribution

Topics: Amines; Animals; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Disease Models, Animal; Excitatory Amino Acid Antagonists; Eye Movements; Gabapentin; gamma-Aminobutyric Acid; Memantine; Nystagmus, Congenital; Syndrome; Zebrafish

Topics: Aging; Alzheimer Disease; Animals; Cheirogaleidae; Disease Models, Animal; Donepezil; Indans; Male; Memantine; Memory Disorders; Piperidines; Sleep Deprivation; Spatial Memory

Topics: Animals; Calcium Signaling; Cysteine; Disease Models, Animal; GABAergic Neurons; HEK293 Cells; Humans; Memantine; Metal Metabolism, Inborn Errors; Mice; Neurodegenerative Diseases; Organophosphorus Compounds; Pterins; Receptors, N-Methyl-D-Aspartate; Synapses; Tungsten Compounds

Topics: Animals; Autistic Disorder; Behavior, Animal; Biomarkers; Brain; Cell Death; Disease Models, Animal; Down-Regulation; Excitatory Amino Acid Antagonists; Gene Expression Profiling; Haploinsufficiency; Humans; Long-Term Potentiation; MEF2 Transcription Factors; Memantine; Mice, Inbred C57BL; Neurogenesis; Neurons; Phenotype; Receptors, N-Methyl-D-Aspartate; Synapses; Synaptic Transmission

Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Galantamine; Humans; Memantine; Neurotransmitter Agents; Nootropic Agents

Topics: Alzheimer Disease; Animals; Behavior, Animal; Dementia; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Memantine; Mitochondria; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Sprague-Dawley; Streptozocin; Tramadol

Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Astrocytes; Brain; Cell Line, Tumor; Culture Media, Conditioned; Disease Models, Animal; Humans; Kallikreins; Memantine; Mice, Knockout; Proteolysis; RNA, Messenger; Up-Regulation

Topics: Animals; Animals, Newborn; Combined Modality Therapy; Disease Models, Animal; Fructose; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Memantine; Neuroprotective Agents; Rats; Rats, Wistar; Topiramate

Topics: Animals; Apoptosis; Brain Injuries, Traumatic; Disease Models, Animal; Male; Memantine; Neuroprotective Agents; Nitrosative Stress; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Recovery of Function

Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Body Weight; Cognition; Diet, High-Fat; Disease Models, Animal; Feeding Behavior; Genotype; Inflammation; Insulin; Liver; Male; Memantine; Mice, Inbred C57BL; Mice, Transgenic; Models, Biological; Obesity; Plaque, Amyloid; Signal Transduction

Topics: Animals; Antioxidants; Biomarkers; Blood Flow Velocity; Brain Ischemia; CA1 Region, Hippocampal; Cerebrovascular Circulation; Cytoprotection; Disease Models, Animal; Hydroxyl Radical; Memantine; Mice, Inbred C57BL; Microdialysis; Neurons; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Reperfusion Injury; Time Factors

Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antiparkinson Agents; Astrocytes; Blood-Brain Barrier; Cell Line; Cell Survival; Cognitive Dysfunction; Disease Models, Animal; Drug Carriers; Drug Compounding; Emulsions; Humans; Male; Maze Learning; Memantine; Mice; Mice, Transgenic; Nanoparticles; Neurons; Particle Size; Plaque, Amyloid; Polyesters; Polyethylene Glycols

Topics: Animals; Body Weight; Cerebral Ventricles; Disease Models, Animal; Excitatory Amino Acid Antagonists; Female; Hydrocephalus; Kaolin; Male; Memantine; Motor Activity; Neuroprotective Agents; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate; Single-Blind Method; White Matter

Topics: Animals; Apoptosis; Brain-Derived Neurotrophic Factor; Cell Proliferation; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Depressive Disorder; Disease Models, Animal; Dopamine; Extracellular Signal-Regulated MAP Kinases; Hippocampus; Inflammation; Male; Memantine; Mice; Microglia; Neuroprotective Agents; Olfactory Bulb

Topics: Amyloid beta-Peptides; Animals; CA1 Region, Hippocampal; Disease Models, Animal; Down Syndrome; Electric Stimulation; Excitatory Amino Acid Antagonists; Female; Humans; Long-Term Potentiation; Male; Memantine; Mice, Inbred C57BL; Mice, Transgenic; Picrotoxin; Prion Proteins

Topics: Animals; Axons; Behavior, Animal; Cognition; Connectome; Disease Models, Animal; Electric Stimulation; Humans; Huntington Disease; Magnetic Resonance Imaging; Male; Memantine; Mice; Motor Activity; Nerve Net; Oxygen; Rest; Somatosensory Cortex; Structure-Activity Relationship

Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Calcium; Cell Cycle; Cells, Cultured; Disease Models, Animal; Excitatory Amino Acid Antagonists; HEK293 Cells; Humans; Intracellular Space; Memantine; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Receptors, N-Methyl-D-Aspartate

Topics: Alzheimer Disease; Animals; CA1 Region, Hippocampal; Disease Models, Animal; Lithium Chloride; Male; Memantine; Neurons; Neuroprotective Agents; Phosphorylation; Polymers; Pyridinium Compounds; Rats, Wistar; Recombinant Proteins; tau Proteins; Tauopathies

Topics: Age Factors; Animals; Autism Spectrum Disorder; Behavior, Animal; Disease Models, Animal; Excitatory Amino Acid Antagonists; Memantine; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Tissue Proteins; Receptors, N-Methyl-D-Aspartate; Social Behavior

Topics: Anhedonia; Animals; Choline; Depression; Disease Models, Animal; Excitatory Amino Acid Antagonists; Glutamic Acid; Glutamine; Hippocampus; Inositol; Magnetic Resonance Spectroscopy; Male; Memantine; Motor Activity; Rats; Rats, Wistar; Schizophrenia; Stress, Psychological; Sucrose; Taurine

Topics: Acetylcholinesterase; Animals; Antidotes; Atropine; Behavior, Animal; Chemical Warfare Agents; Cholinesterase Inhibitors; Diazepam; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; GPI-Linked Proteins; Male; Memantine; Neuromuscular Junction; Organophosphate Poisoning; Oximes; Pyridinium Compounds; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Soman; Synaptic Transmission

Topics: Animals; Bayes Theorem; Computer Simulation; Disease Models, Animal; Down Syndrome; Gene Expression; Humans; Immune System Phenomena; Learning; Memantine; Mice; Nerve Tissue Proteins; Neural Networks, Computer; Support Vector Machine; Trisomy

Topics: Animals; Behavior, Animal; Cognition; Disease Models, Animal; Dopamine Agonists; Excitatory Amino Acid Antagonists; Learning; Male; Memantine; Motor Activity; Obsessive-Compulsive Disorder; Quinpirole; Rats; Rats, Long-Evans; Riluzole

Topics: Animals; Animals, Newborn; Auditory Cortex; Behavior, Animal; Cognitive Dysfunction; Corpus Striatum; Disease Models, Animal; Evoked Potentials; Excitatory Amino Acid Antagonists; Female; Hippocampus; Male; Maternal Deprivation; Maze Learning; Memantine; Prefrontal Cortex; Pregnancy; Rats; Rats, Sprague-Dawley; Schizophrenia

Topics: Administration, Oral; Animals; Anxiety; Behavior, Animal; Biogenic Monoamines; Body Weight; Dementia; Depression; Disease Models, Animal; Glutamic Acid; Hippocampus; Locomotion; Male; Maze Learning; Memantine; Memory; Mice; Thiamine Deficiency

Topics: Animals; Behavior, Animal; Brain Injuries, Traumatic; Cerebral Cortex; Disease Models, Animal; Excitatory Amino Acid Antagonists; Hippocampus; Male; Memantine; Motor Activity; Nerve Degeneration; Rats; Receptors, N-Methyl-D-Aspartate; Spatial Memory; Time Factors; Vestibule, Labyrinth

Topics: Animals; Brain Injuries; Disease Models, Animal; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Male; Memantine; Mice; Mice, Inbred C57BL; Nimodipine; Nitrates; Nitric Oxide; Rabbits; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Subarachnoid Hemorrhage; Vasodilator Agents; Vasospasm, Intracranial

Topics: Animals; Antineoplastic Agents; Behavior, Animal; Cisplatin; Disease Models, Animal; Excitatory Amino Acid Antagonists; Male; Memantine; Mice, Inbred BALB C; N-Methylaspartate; Neuroprotective Agents; Neurotoxicity Syndromes; Psychomotor Performance

Topics: Animals; Behavior, Animal; Codon, Nonsense; Disease Models, Animal; Epileptic Syndromes; Excitatory Amino Acid Antagonists; Female; GABAergic Neurons; Humans; Male; Memantine; Mice; Mice, Inbred C57BL; Mice, Knockout; Prosencephalon; Protein Serine-Threonine Kinases; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Spasms, Infantile; Treatment Outcome

Topics: Animals; Disease Models, Animal; Dopamine Agents; Electroretinography; Female; Follow-Up Studies; Glaucoma, Angle-Closure; Intraocular Pressure; Memantine; Mice; Mice, Inbred DBA; Microscopy, Confocal; Retina; Time Factors; Treatment Outcome

Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Avoidance Learning; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fingolimod Hydrochloride; Gene Expression Profiling; Gene Expression Regulation; Hippocampus; Male; Memantine; Mitogen-Activated Protein Kinases; Nerve Degeneration; Neuroprotective Agents; Peptide Fragments; Propylene Glycols; Rats; Rats, Sprague-Dawley; Sex Factors; Sphingosine

Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Brain; Chromatography, Liquid; Disease Models, Animal; Male; Mass Spectrometry; Memantine; Mice; Mice, Transgenic

Topics: Animals; Disease Models, Animal; Disease Progression; Excitatory Amino Acid Antagonists; Memantine; Mice; Mice, Knockout; Motor Activity; Neuronal Ceroid-Lipofuscinoses; Receptors, N-Methyl-D-Aspartate; Rotarod Performance Test; Thiolester Hydrolases; Treatment Outcome

Topics: Analgesics, Opioid; Animals; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Male; Memantine; Mice; Morphine; Morphine Dependence; Naloxone; Pain; Vitamin B 12

Topics: Animals; Atrophy; Cell Death; Cognition Disorders; Depressive Disorder; Disease Models, Animal; Hippocampus; Male; Memantine; Memory Disorders; Neurodegenerative Diseases; Neuroimmunomodulation; Neuroprotective Agents; Nootropic Agents; Olfaction Disorders; Olfactory Bulb; Psychomotor Agitation; Rats; Rats, Sprague-Dawley; Space Perception; Zinc Sulfate

Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Drug Delivery Systems; Excitatory Amino Acid Antagonists; Glioma; Memantine; Mice; Polymers; Rats; Riluzole

Topics: Amantadine; Animals; Antiparkinson Agents; Disease Models, Animal; Dyskinesias; Excitatory Amino Acid Antagonists; Levodopa; Male; Memantine; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley

Topics: Animals; Disease Models, Animal; Excitatory Amino Acid Antagonists; Facial Injuries; Facial Nerve; Facial Nerve Injuries; Female; Memantine; Rats; Rats, Wistar; Recovery of Function

Topics: Animals; Cognition; Dextromethorphan; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Hyperalgesia; Male; Maze Learning; Memantine; Neuralgia; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate

Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Glutamic Acid; Ligands; Male; Memantine; Motor Activity; N-Methylaspartate; Piperazines; Prefrontal Cortex; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Sulfonamides; Swimming

Topics: Alcohol Drinking; Alcoholism; Animals; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Memantine; Motivation; Motor Activity; Rats; Rats, Long-Evans; Recurrence

Topics: Animals; Antioxidants; Body Weight; Brain; Brain Infarction; Cresols; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Hormones; Infarction, Middle Cerebral Artery; Male; Memantine; Mice, Inbred C57BL; Motor Activity; Neuroprotective Agents

Topics: Animals; Animals, Newborn; Disease Models, Animal; Female; Male; Memantine; N-Methylaspartate; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Seizures

Topics: Animals; Animals, Newborn; Asphyxia Neonatorum; Brain; Brain Ischemia; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Gerbillinae; Immunohistochemistry; Ischemic Preconditioning; Male; Memantine; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate

Topics: Animal Feed; Animals; Binge-Eating Disorder; Compulsive Behavior; Conditioning, Operant; Conflict, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Excitatory Amino Acid Antagonists; Fasting; Feeding Behavior; Lighting; Male; Memantine; Motivation; Nucleus Accumbens; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reinforcement Schedule

Topics: Animals; Animals, Newborn; Brain; Brain Ischemia; Cell Hypoxia; Cell Proliferation; Cell Survival; Cells, Cultured; Disease Models, Animal; Glial Cell Line-Derived Neurotrophic Factor; Glucose; Leukomalacia, Periventricular; Memantine; Neural Stem Cells; Neurogenesis; Neuroglia; Neuroprotective Agents; Random Allocation; Rats, Inbred SHR; Stem Cell Niche; Uridine Diphosphate Glucose; White Matter

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Calcium Signaling; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Hippocampus; In Vitro Techniques; Male; Memantine; Membrane Glycoproteins; Memory Disorders; Memory, Long-Term; Mice, Inbred C57BL; Neuronal Plasticity; Parkinsonian Disorders; Protein-Tyrosine Kinases; Signal Transduction; Synapses; Time Factors

Topics: Animals; Brain Injuries; Disease Models, Animal; Drug Therapy, Combination; Estradiol; Estrogens; Hippocampus; Memantine; Neuroprotective Agents; Organ Culture Techniques; Rats; Rats, Sprague-Dawley

Topics: Animals; Disease Models, Animal; Down Syndrome; Learning; Memantine; Mice; Protein Subunits; Proteome; Proteomics; Receptors, N-Methyl-D-Aspartate

Topics: Alzheimer Disease; Analysis of Variance; Animals; Disease Models, Animal; Electroretinography; Ependymoglial Cells; Evoked Potentials, Visual; Glutamate-Ammonia Ligase; MAP Kinase Signaling System; Memantine; Mice; Mice, Transgenic; Microglia; Nerve Degeneration; Neuroprotective Agents; Phosphorylation; Retinal Ganglion Cells

Topics: Acute Lung Injury; Amino Acids; Animals; Antibiotics, Antineoplastic; Bleomycin; Bronchoalveolar Lavage Fluid; Capillary Permeability; CD11b Antigen; Cytokines; Disease Models, Animal; Dopamine Agents; Female; Glutamic Acid; Malondialdehyde; Memantine; Mice; Neutrophil Infiltration; Neutrophils; Receptors, N-Methyl-D-Aspartate

Topics: Animals; Blotting, Western; Disease Models, Animal; Endothelium, Vascular; Excitatory Amino Acid Antagonists; Male; Memantine; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Vasospasm, Intracranial

Topics: Animals; Cluster Analysis; Disease Models, Animal; Down Syndrome; Gene Expression Regulation; Humans; Learning; Memantine; Memory Disorders; Mice; Protein Interaction Maps

Topics: Administration, Intravenous; Aging; Amino Acid Transport System X-AG; Animals; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dopamine Uptake Inhibitors; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Maternal Deprivation; Memantine; Rats; Receptors, N-Methyl-D-Aspartate; Reward; Riluzole; Self Administration; Stress, Psychological

Topics: Analysis of Variance; Animals; Apoptosis; Calcium; Cognition Disorders; CREB-Binding Protein; Disease Models, Animal; Excitatory Amino Acid Antagonists; Flow Cytometry; Hippocampus; Hypoxia; Male; MAP Kinase Signaling System; Maze Learning; Memantine; Mice; Mice, Inbred ICR; Receptors, N-Methyl-D-Aspartate; Time Factors

Topics: Administration, Cutaneous; Administration, Intravenous; Administration, Oral; Alzheimer Disease; Animals; Area Under Curve; Biological Availability; Disease Models, Animal; Dose-Response Relationship, Drug; Half-Life; Memantine; Nootropic Agents; Rats; Transdermal Patch

Topics: Alcoholism; Animals; Conditioning, Psychological; Cues; Disease Models, Animal; Ethanol; Extinction, Psychological; Male; Memantine; Memory; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Recurrence; Self Administration

Topics: Amyloid beta-Peptides; Animals; Cholinesterase Inhibitors; Disease Models, Animal; Donepezil; Drug Synergism; Excitatory Amino Acid Antagonists; Furans; Indans; Male; Memantine; Memory Disorders; Mice; Morpholines; Neuroprotective Agents; Peptide Fragments; Piperidines; Receptors, N-Methyl-D-Aspartate; Receptors, sigma; Sigma-1 Receptor

Topics: Aging; Alzheimer Disease; Animals; beta-Galactosidase; Cholinesterase Inhibitors; Cognition; Disease Models, Animal; Donepezil; Glutamic Acid; Hippocampus; Indans; Male; Maze Learning; Memantine; Memory; Mice; Neuronal Plasticity; Nitric Oxide Synthase Type I; PC12 Cells; Piperidines; Rats; Receptors, N-Methyl-D-Aspartate

Topics: Alzheimer Disease; Animals; Behavior, Animal; Blotting, Western; Cognition Disorders; Dependovirus; Disease Models, Animal; Dopamine Agents; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Intracellular Signaling Peptides and Proteins; Male; Memantine; Nuclear Proteins; Protein Phosphatase 2; Rats; Rats, Wistar; RNA-Binding Proteins

Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Case-Control Studies; Cerebral Cortex; Dendritic Spines; Diabetes Mellitus, Type 2; Disease Models, Animal; Dynamins; Excitatory Amino Acid Antagonists; Female; Glucose; GTP Phosphohydrolases; Hippocampus; Humans; Hyperglycemia; Immunoblotting; Induced Pluripotent Stem Cells; Insulin; Insulysin; Long-Term Potentiation; Male; Memantine; Metabolic Syndrome; Mice; Mice, Transgenic; Microtubule-Associated Proteins; Mitochondrial Proteins; Neurons; Nitric Oxide; Nitroso Compounds; Oxygen Consumption; Rats; Reactive Nitrogen Species; Synapses

Topics: Alzheimer Disease; Animals; Cell Adhesion; Colchicine; Cytotoxicity, Immunologic; Disease Models, Animal; Humans; Immunomodulation; Inflammation Mediators; Infusions, Intraventricular; Male; Memantine; Mice; Neurogenic Inflammation; Neurotoxins; Phagocytosis; Rats; Receptors, N-Methyl-D-Aspartate

Topics: Alzheimer Disease; Animals; Cognition Disorders; Disease Models, Animal; Dopamine Agents; Memantine; Mice; Mice, Inbred C57BL; Mice, Transgenic

Topics: Animals; Apoptosis; Blotting, Western; Cochlea; Disease Models, Animal; Gentamicins; Guinea Pigs; In Situ Nick-End Labeling; Memantine; Republic of Korea; Signal Transduction; Spiral Ganglion

Topics: Animals; Autistic Disorder; Blood-Brain Barrier; Brain; Disease Models, Animal; Excitatory Amino Acid Antagonists; Exploratory Behavior; Female; Interpersonal Relations; Locomotion; Male; Maze Learning; Memantine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Valproic Acid

Topics: Animals; Corpus Striatum; Disease Models, Animal; Glutamic Acid; Huntington Disease; Memantine; Mice; Receptors, N-Methyl-D-Aspartate; Synapses; Synaptic Transmission

Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Antidepressive Agents; Central Nervous System Stimulants; Depression; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Imipramine; Male; Memantine; Memory Disorders; Muscarinic Antagonists; Nootropic Agents; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Scopolamine; Substance Withdrawal Syndrome

Topics: Acetylcholinesterase; Animals; Brain Waves; Cholinesterase Reactivators; Computer Simulation; Disease Models, Animal; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocampus; Male; Memantine; Membrane Potentials; Mice; Models, Neurological; Neurons; Neurotoxicity Syndromes; Organophosphates; Oximes; Paraoxon; Pyridinium Compounds

Topics: Animals; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Insulin; Male; Maze Learning; Memantine; Memory Disorders; Motor Activity; Nootropic Agents; Rats, Sprague-Dawley; Spatial Memory; Visual Perception

Topics: alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Animals; Antiparkinson Agents; Cholinesterase Inhibitors; Cognition; Disease Models, Animal; Galantamine; Male; Memantine; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic

Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Male; Memantine; Necrosis; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Spinal Cord Injuries

Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cognition; Disease Models, Animal; Donepezil; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Female; Indans; Male; Memantine; Memory; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Neuroimmunomodulation; Neuroprotective Agents; Peptide Fragments; Phenotype; Piperazines; Piperidines; Pyridazines; Random Allocation; Rats, Sprague-Dawley

Topics: Animals; Animals, Newborn; Apoptosis; CA1 Region, Hippocampal; Disease Models, Animal; Hyperbaric Oxygenation; Hypoxia; Hypoxia-Ischemia, Brain; Memantine; Neuroprotection; Neuroprotective Agents; Oxygen; Rats; Rats, Wistar; Reactive Oxygen Species

Topics: Animals; Brain; Brain Ischemia; Carotid Artery, Common; Disease Models, Animal; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Glutamic Acid; Glutathione; Male; Memantine; Mice; Neuroprotective Agents; Nitric Oxide; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Time Factors

Topics: Animals; Benzylamines; Depression; Disease Models, Animal; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Gene Expression Regulation; Hippocampus; In Vitro Techniques; Ketamine; Memantine; Phosphinic Acids; Phosphorylation; Picrotoxin; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Swimming; Synaptic Transmission; Synaptosomes

Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Galantamine; Memantine; Mice; Mice, Transgenic; Peptide Fragments

Topics: Alzheimer Disease; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Dendrites; Disease Models, Animal; Hippocampus; Humans; Long-Term Potentiation; Memantine; Memory; Memory Disorders; Mice; Mice, Transgenic; Neurons; Phosphorylation; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pyramidal Cells; Synapses; Temporal Lobe

Topics: Animals; Antidepressive Agents; Brain; Brain-Derived Neurotrophic Factor; Depressive Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Male; Memantine; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Sertraline

Topics: Animals; Astrocytes; Disease Models, Animal; Glial Fibrillary Acidic Protein; Intravitreal Injections; Memantine; Mice, Inbred BALB C; Nerve Crush; Neuroglia; Neuroprotection; Observer Variation; Optic Nerve; Retina

Topics: Animals; Animals, Newborn; Antigens, Differentiation; Biomarkers; Brain; Disease Models, Animal; Excitatory Amino Acid Antagonists; Humans; Hypoxia-Ischemia, Brain; Infant, Newborn; Leukomalacia, Periventricular; Male; Memantine; Myelin Basic Protein; Nerve Fibers, Myelinated; Oligodendroglia; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate; Wallerian Degeneration

Topics: 3,4-Methylenedioxyamphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Cognition; Cognition Disorders; Discrimination, Psychological; Disease Models, Animal; Excitatory Amino Acid Antagonists; Exploratory Behavior; Male; Maze Learning; Memantine; Mice; Motor Activity; Nicotinic Antagonists; Rats; Rats, Long-Evans; Recognition, Psychology; Time Factors

Topics: Ammonia; Animals; Brain; Disease Models, Animal; Disease Progression; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Galactosamine; Hepatic Encephalopathy; Hyperammonemia; Infusion Pumps, Implantable; Liver Failure, Acute; Male; Memantine; Microdialysis; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Severity of Illness Index; Time Factors

Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Disease Models, Animal; Exploratory Behavior; Magnetic Resonance Imaging; Memantine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Recognition, Psychology

Topics: Adult; Aged; Animals; Cerebral Palsy; Child; Controlled Clinical Trials as Topic; Dantrolene; Disease Models, Animal; Dopamine Agents; Humans; Memantine; Middle Aged; Multiple Sclerosis; Muscle Hypotonia; Muscle Relaxants, Central; Muscle Spasticity; Muscle Tonus; Myofascial Pain Syndromes; Neuromuscular Agents; Rats

Topics: Animals; Disease Models, Animal; Esophagus; Hydrocephalus; Memantine; Muscle Contraction; Muscle, Smooth; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Stomach

Topics: Animals; Cell Death; Disease Models, Animal; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Follow-Up Studies; Geniculate Bodies; Male; Memantine; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neuroprotective Agents; Retina; Retinal Diseases; Retinal Ganglion Cells; Superior Colliculi; Visual Pathways

Topics: Animals; Brain Ischemia; Disease Models, Animal; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Male; Memantine; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Sodium Nitrite; Stroke

Topics: Amines; Analgesics; Animals; Cyclohexanecarboxylic Acids; Cyclopentanes; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Male; Memantine; Pain; Pain Measurement; Physical Stimulation; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Streptozocin; Time Factors

Topics: Animals; Animals, Newborn; Anticonvulsants; Apoptosis; Brain; Brain Infarction; Disease Models, Animal; Excitatory Amino Acid Antagonists; Female; Fructose; Glutamic Acid; Hypoxia-Ischemia, Brain; In Situ Nick-End Labeling; Male; Memantine; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Rats; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Topiramate; Treatment Outcome

Topics: Animals; Brain Mapping; Cells, Cultured; Chronic Disease; Cytoskeletal Proteins; Disease Models, Animal; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Exploratory Behavior; Gene Expression; Genes, Immediate-Early; Hippocampus; In Situ Hybridization, Fluorescence; Lipopolysaccharides; Male; Memantine; Microglia; Nerve Net; Nerve Tissue Proteins; Neurogenic Inflammation; Neurons; Rats; Rats, Inbred F344; Receptors, N-Methyl-D-Aspartate; RNA, Messenger

Topics: Animals; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Fluoxetine; Male; Memantine; Mice; Obsessive-Compulsive Disorder; p-Methoxy-N-methylphenethylamine; Receptors, N-Methyl-D-Aspartate

Topics: Animals; Antioxidants; Biomarkers; Brain; Cholinesterase Inhibitors; Cyclic N-Oxides; Disease Models, Animal; Excitatory Amino Acid Antagonists; Injections, Intraperitoneal; Isoflurophate; Lipid Peroxidation; Male; Memantine; Neurodegenerative Diseases; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Seizures; Time Factors; Vitamin A

Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; CD11b Antigen; Disease Models, Animal; Hydrolases; Immunohistochemistry; Infusions, Parenteral; Male; Memantine; Peptide Fragments; Protein-Arginine Deiminase Type 2; Protein-Arginine Deiminases; Rats; Rats, Wistar; Solubility

Topics: Analgesics; Animals; Brain; CD11 Antigens; Disease Models, Animal; Excitatory Amino Acid Antagonists; Hyperalgesia; Hypothalamus; Male; Memantine; Microglia; Neuralgia; Neuropeptides; Periaqueductal Gray; Peripheral Nervous System Diseases; Rats; Rats, Wistar; Sciatic Neuropathy; Somatostatin; Substance P

Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Biomarkers; Brain; CD11 Antigens; Disease Models, Animal; Excitatory Amino Acid Antagonists; Glial Fibrillary Acidic Protein; Gliosis; Hippocampus; Male; Memantine; Nerve Degeneration; Neuroglia; Neuropeptides; Nitric Oxide Synthase Type II; Oxidative Stress; Peptide Fragments; Peptide Hydrolases; Rats; Rats, Wistar; Somatostatin; Substance P

Topics: Animals; Behavior, Animal; Disease Models, Animal; Hyperalgesia; Male; Memantine; Methadone; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate

Topics: Animals; Brain; Calcium Signaling; Cholinesterase Inhibitors; Dementia; Disease Models, Animal; Donepezil; Drug Evaluation, Preclinical; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glutathione; Indans; Injections, Intraventricular; Male; Malondialdehyde; Maze Learning; Memantine; Memory; Memory Disorders; Neuropsychological Tests; Nitrites; Okadaic Acid; Oxidative Stress; Piperidines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Treatment Outcome

Topics: Alzheimer Disease; Amyloid; Animals; Antiparkinson Agents; Clinical Trials as Topic; Concept Formation; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Memantine; Mice; Mice, Transgenic; Species Specificity

Topics: Age Factors; Aging; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antiparkinson Agents; Cognition; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Male; Memantine; Mice; Mice, Transgenic; Phosphorylation; Protein Kinases; Protein Multimerization; tau Proteins

Topics: Animals; Brain; Brain Chemistry; Cell Survival; Disease Models, Animal; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Homeostasis; Hypoxia, Brain; Male; Memantine; Mice; Mice, Inbred ICR; Nerve Degeneration; Neurons; Phosphorylation; Shab Potassium Channels; Stress, Physiological; Time Factors

Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Avoidance Learning; Disease Models, Animal; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Excitatory Amino Acid Antagonists; Folic Acid; Gene Expression Profiling; Humans; Maze Learning; Memantine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neurons; Oligonucleotide Array Sequence Analysis; Peptide Fragments; Reaction Time; Spatial Behavior; Time Factors; Up-Regulation; Vitamin B Complex

Topics: Animals; Brain; Brain-Derived Neurotrophic Factor; Cholinergic Fibers; Chromosomes, Mammalian; Disease Models, Animal; Down Syndrome; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Male; Maze Learning; Memantine; Memory Disorders; Mice; Mice, Mutant Strains; Motor Activity; Nerve Degeneration; Recognition, Psychology; Trisomy

Topics: Animals; Behavior, Animal; Cisterna Magna; Disease Models, Animal; Excitatory Amino Acid Antagonists; Facial Pain; Formaldehyde; Injections; Injections, Subcutaneous; Kynurenic Acid; Male; Memantine; Motor Activity; Nociceptors; Phenols; Piperazines; Piperidines; Pruritus; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission; Time Factors; Vibrissae

Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Cues; Disease Models, Animal; Down Syndrome; Exploratory Behavior; Gait Disorders, Neurologic; Gene Expression Regulation; Humans; Maze Learning; Memantine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phenotype; Psychomotor Performance; Reaction Time; Rotarod Performance Test; Space Perception; Vesicular Glutamate Transport Protein 1

Topics: Animals; Cerebellum; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Hypoxia, Brain; Male; Memantine; Myoclonus; Nerve Degeneration; Purkinje Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate

Topics: Animals; Disease Models, Animal; Female; Humans; Injections, Intraperitoneal; Male; Memantine; Rats; Rats, Wistar; Spinal Cord Injuries; Urinary Bladder, Overactive

Topics: Aging; Amyloid beta-Peptides; Animals; Attention; Avoidance Learning; Cholinergic Fibers; Dementia; Disease Models, Animal; Humans; Male; Memantine; Microglia; Nerve Degeneration; Peptide Fragments; Prosencephalon; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate

Topics: Animals; Binge-Eating Disorder; Dietary Fats; Disease Models, Animal; Eating; Feeding Behavior; Humans; Male; Memantine; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate

Topics: Animals; Behavior, Animal; Cadherins; Compulsive Behavior; Disease Models, Animal; Dog Diseases; Dogs; Excitatory Amino Acid Antagonists; History, 20th Century; History, 21st Century; Humans; Memantine; Obsessive-Compulsive Disorder; Stereotyped Behavior; United States; Veterinary Medicine

Topics: Analysis of Variance; Animals; Antipsychotic Agents; Autoradiography; Biological Transport; Brain; Bridged Bicyclo Compounds, Heterocyclic; Carbon Radioisotopes; Cyclic S-Oxides; Deoxyglucose; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; High-Throughput Screening Assays; Ketamine; Male; Memantine; Mice; Mice, Inbred C57BL; Receptors, Metabotropic Glutamate; Reproducibility of Results; Schizophrenia

Topics: Action Potentials; Animals; Antimanic Agents; Bipolar Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Exploratory Behavior; Hippocampus; In Vitro Techniques; Lithium Chloride; Male; Memantine; Ouabain; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Time Factors

Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Avoidance Learning; Discrimination, Psychological; Disease Models, Animal; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Male; Maze Learning; Memantine; Mice; Mice, Neurologic Mutants; Nesting Behavior; Presenilin-1

Topics: Animals; Blotting, Western; Brain; Disease Models, Animal; Dopamine Agents; Immunohistochemistry; Long-Term Potentiation; Male; Memantine; Methyl-CpG-Binding Protein 2; Mice; Neuronal Plasticity; Patch-Clamp Techniques; Rett Syndrome

Topics: Animals; Antidepressive Agents; Behavior, Animal; Depressive Disorder; Disease Models, Animal; Excitatory Amino Acid Antagonists; Male; Memantine; Neuronal Plasticity; Prefrontal Cortex; Rats; Rats, Wistar; Stress, Psychological

Topics: Animals; Brimonidine Tartrate; Cell Count; Disease Models, Animal; Hyperbaric Oxygenation; Immunohistochemistry; Injections, Intravenous; Memantine; Neuroprotective Agents; Ophthalmic Solutions; Quinoxalines; Rats; Rats, Wistar; Reperfusion Injury; Retina; Retinal Ganglion Cells

Topics: Aluminum; Analysis of Variance; Animals; Body Weight; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Escape Reaction; Excitatory Amino Acid Antagonists; Exploratory Behavior; Male; Maze Learning; Memantine; Rats; Rats, Wistar; Rotarod Performance Test; Time Factors

Topics: Analysis of Variance; Animals; Calpain; Caspase 3; Cell Death; Corpus Striatum; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Fluoresceins; Globus Pallidus; Male; Manganese; Manganese Poisoning; Memantine; Nerve Tissue Proteins; Neurons; Organic Chemicals; Rats; Rats, Wistar; Time Factors

Topics: Animals; Conditioning, Classical; Disease Models, Animal; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Hippocampus; Hypoglycemic Agents; Infusions, Intraventricular; Lithium; Male; Memantine; Memory Disorders; Neuroprotective Agents; Physostigmine; Pioglitazone; Prefrontal Cortex; Rats; Rats, Wistar; Statistics, Nonparametric; Streptozocin; Thiazolidinediones

Topics: Analysis of Variance; Animals; Disease Models, Animal; Down Syndrome; Electric Stimulation; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Long-Term Synaptic Depression; Memantine; Methoxyhydroxyphenylglycol; Mice; Mice, Mutant Strains; N-Methylaspartate; Time Factors; Trisomy

Topics: Aldosterone; Analysis of Variance; Animals; Body Weight; Bromodeoxyuridine; Cell Count; Cell Proliferation; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Excitatory Amino Acid Antagonists; Exploratory Behavior; Hippocampus; Male; Memantine; Myocardium; Radioimmunoassay; Rats; Rats, Wistar; Renin; Stress, Psychological; Time Factors

Topics: Alzheimer Disease; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Male; Maze Learning; Memantine; Memory; Placebos; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate

Topics: Alzheimer Disease; Animals; Cholinesterase Inhibitors; Disease Models, Animal; Donepezil; Drug Synergism; Excitatory Amino Acid Antagonists; Indans; Male; Maze Learning; Memantine; Memory; Mice; Mice, Transgenic; Motor Activity; Piperidines; Rest; Spatial Behavior

Topics: Animals; Axons; Case-Control Studies; Disease Models, Animal; Evoked Potentials, Visual; Excitatory Amino Acid Antagonists; Female; Glaucoma; Intraocular Pressure; Macaca fascicularis; Male; Memantine; Optic Nerve; Photography; Scanning Laser Polarimetry

Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Disease Models, Animal; Electric Stimulation; Long-Term Synaptic Depression; Memantine; Mice; Mice, Transgenic; Plaque, Amyloid; Recognition, Psychology; Sensory Deprivation; Temporal Lobe

Topics: Alzheimer Disease; Animals; Carcinogens; Chromatography, High Pressure Liquid; Cyclin-Dependent Kinase 5; Disease Models, Animal; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Exploratory Behavior; Glutamic Acid; Hippocampus; Locomotion; Male; Maze Learning; Memantine; Okadaic Acid; Rats; Rats, Wistar; Signal Transduction; Statistics as Topic; tau Proteins

Topics: Animals; Autistic Disorder; Cell Adhesion; Cell Movement; Cells, Cultured; Cerebellum; Dendritic Spines; Disease Models, Animal; Fragile X Mental Retardation Protein; Fragile X Syndrome; Memantine; Mice; Mice, Inbred C57BL; Mice, Knockout; Synapses

Topics: Animals; Apoptosis; Cerebral Cortex; Coculture Techniques; Corpus Striatum; Disease Models, Animal; Excitatory Amino Acid Antagonists; Huntington Disease; Memantine; Mice; Mice, Transgenic; Neurons; Piperidines; Receptors, N-Methyl-D-Aspartate; Signal Transduction

Topics: Aging; Animals; Cerebral Cortex; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Drug Resistance; Excitatory Amino Acid Antagonists; Female; Male; Memantine; Membrane Glycoproteins; Mice; Mice, 129 Strain; Mice, Knockout; Molecular Chaperones; Molecular Targeted Therapy; Motor Skills; Nerve Tissue Proteins; Neuronal Ceroid-Lipofuscinoses; Neurons; Organ Specificity; Receptors, N-Methyl-D-Aspartate

Topics: Analgesics, Opioid; Animals; Discrimination Learning; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Tolerance; Excitatory Amino Acid Antagonists; Male; Memantine; Morphine; Pain; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, mu; Reinforcement Schedule

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Ibuprofen; Injections, Intraventricular; Male; Maze Learning; Memantine; Memory Disorders; Motor Activity; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitrites; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Statistics, Nonparametric; Streptozocin

Topics: Amnesia; Animals; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Galantamine; Male; Memantine; Mice; Mice, Inbred Strains; Recognition, Psychology; Scopolamine

Topics: Animals; Brain Infarction; Brain Mapping; Calcium; Cognition Disorders; Disease Models, Animal; Dizocilpine Maleate; Glial Fibrillary Acidic Protein; Humans; Imaging, Three-Dimensional; Infarction, Middle Cerebral Artery; Male; Memantine; Microscopy, Confocal; Microvessels; Models, Biological; Neural Pathways; Neuroprotective Agents; Phosphopyruvate Hydratase; Psychomotor Performance; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Somatosensory Cortex; Vibrissae

Topics: Alzheimer Disease; Animals; Brain; Cholinesterase Inhibitors; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Donepezil; Female; Indans; Maze Learning; Memantine; Memory; Memory Disorders; Mice; Mice, Transgenic; Nootropic Agents; Piperidines; Receptors, AMPA

Topics: Alkaloids; Amino Acids; Animals; Anticonvulsants; Antioxidants; Atropine; Benzodioxoles; Biogenic Monoamines; Brain; Diazepam; Disease Models, Animal; Epilepsy; Flumazenil; gamma-Aminobutyric Acid; Humans; Male; Memantine; Mice; Nimodipine; Nitrites; Pilocarpine; Piperidines; Polyunsaturated Alkamides; Seizures; Tumor Necrosis Factor-alpha

Topics: Analysis of Variance; Animals; Cerebral Cortex; Cerebral Infarction; Corpus Striatum; Disease Models, Animal; DNA Fragmentation; Immunoglobulin G; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Male; MAP Kinase Signaling System; Melatonin; Memantine; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Phosphorylation; Signal Transduction

Topics: Aging; Analysis of Variance; Animals; Antihypertensive Agents; Brimonidine Tartrate; Cell Survival; Disease Models, Animal; Glaucoma; Memantine; Mice; Mice, Inbred DBA; Quinoxalines; Retinal Ganglion Cells; Timolol

Topics: Animals; Ataxia; Behavior, Animal; Catalepsy; Diamines; Disease Models, Animal; Dizocilpine Maleate; Dopamine Antagonists; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Haloperidol; Kainic Acid; Memantine; Mice; Mice, Inbred Strains; N-Methylaspartate; Quaternary Ammonium Compounds; Seizures; Structure-Activity Relationship; Time Factors

Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Apomorphine; Avoidance Learning; Biguanides; Brain Chemistry; Chlordiazepoxide; Clonidine; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Droperidol; Drug Interactions; GABA Agents; GABA Antagonists; GABA Modulators; gamma-Aminobutyric Acid; Glutamic Acid; Male; Memantine; Mephenytoin; Microinjections; Pentylenetetrazole; Phentolamine; Picrotoxin; Piperazines; Propranolol; Pyrimidines; Rats; Serotonin; Sulpiride; Ventromedial Hypothalamic Nucleus; Yohimbine

Topics: 5-Hydroxytryptophan; Animals; Body Temperature; Clorgyline; Disease Models, Animal; Dizocilpine Maleate; Drug Interactions; Excitatory Amino Acid Antagonists; Fever; Hypothalamus; Ketamine; Male; Memantine; Microdialysis; Norepinephrine; Rats; Rats, Wistar; Risperidone; Serotonin; Serotonin Antagonists; Serotonin Syndrome; Time Factors

Topics: Adrenergic beta-Agonists; Animals; Brain Ischemia; Cells, Cultured; Clenbuterol; Disease Models, Animal; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Glutamates; Hippocampus; Memantine; Mice; Neurons; Neuroprotective Agents; Rats; Rats, Inbred F344; Receptors, N-Methyl-D-Aspartate; Staurosporine; Stroke

Topics: Acetylcholine; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Choline O-Acetyltransferase; Cholinergic Fibers; Disease Models, Animal; Down-Regulation; Encephalitis; Genetic Predisposition to Disease; Gliosis; Humans; Male; Memantine; Mice; Mice, Transgenic; Mutation; Neurons; Neurotoxins; Prosencephalon; Receptors, N-Methyl-D-Aspartate; Tumor Necrosis Factor-alpha

Topics: Amines; Animals; Chronic Disease; Cyclohexanecarboxylic Acids; Cyclohexanols; Disease Models, Animal; Gabapentin; gamma-Aminobutyric Acid; Memantine; Pain; Pain Threshold; Pregabalin; Prodrugs; Rats; Sciatic Neuropathy; Structure-Activity Relationship; Venlafaxine Hydrochloride

Topics: Alzheimer Disease; Animals; Blotting, Western; Brain; Disease Models, Animal; Dopamine Agents; Electrophoresis, Polyacrylamide Gel; Excitatory Amino Acid Agonists; Ibotenic Acid; Immunohistochemistry; Male; Memantine; Neuroglia; Neuropeptides; Peptide Hydrolases; Rats; Rats, Wistar

Topics: Administration, Oral; Animals; Cell Count; Chronic Disease; Disease Models, Animal; Electroretinography; Evoked Potentials, Visual; Excitatory Amino Acid Antagonists; Glaucoma; Glutamic Acid; Intraocular Pressure; Macaca fascicularis; Memantine; Ocular Hypertension; Optic Nerve Diseases; Retina; Retinal Ganglion Cells; Safety; Treatment Outcome; Vitreous Body

Topics: Administration, Oral; Animals; Cell Count; Cell Survival; Disease Models, Animal; Excitatory Amino Acid Antagonists; Glaucoma; Intraocular Pressure; Macaca fascicularis; Memantine; Ocular Hypertension; Optic Disk; Optic Nerve Diseases; Retina; Retinal Ganglion Cells; Safety; Treatment Outcome

Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cholinesterase Inhibitors; Cognition; Disease Models, Animal; Donepezil; Dose-Response Relationship, Drug; Galantamine; Humans; Indans; Male; Memantine; Mice; Mice, Mutant Strains; Phenylcarbamates; Piperidines; Rivastigmine; Sensitivity and Specificity

Topics: Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloidosis; Animals; Brain; Brain Chemistry; Cell Count; Disease Models, Animal; Dose-Response Relationship, Drug; Fluorescent Dyes; Humans; Imaging, Three-Dimensional; Immunohistochemistry; Magnetic Resonance Imaging; Memantine; Mice; Mice, Transgenic; Phosphopyruvate Hydratase; Plaque, Amyloid; Radionuclide Imaging; Staining and Labeling; Time Factors; Tritium

Topics: Animals; Brain; Brain Injuries; Disease Models, Animal; Excitatory Amino Acid Antagonists; Head Injuries, Closed; Lipid Peroxidation; Male; Malondialdehyde; Memantine; Rats; Rats, Sprague-Dawley; Time Factors

Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Cholinesterase Inhibitors; Cognition; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Excitatory Amino Acid Antagonists; Galantamine; Humans; Maze Learning; Memantine; Mice; Mice, Transgenic; Motor Activity; Neuropsychological Tests; Random Allocation; Reaction Time; Time Factors

Topics: Animals; Cerebral Hemorrhage; Disease Models, Animal; Gene Expression Regulation; Hematoma; Male; Matrix Metalloproteinases; Memantine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tissue Plasminogen Activator; Treatment Outcome; Urokinase-Type Plasminogen Activator

Topics: Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Humans; Immunohistochemistry; Memantine; Mice; Mice, Transgenic; Receptors, N-Methyl-D-Aspartate; Spinal Cord; Superoxide Dismutase; Survival Analysis; Time Factors; Treatment Outcome

Topics: Analysis of Variance; Animals; Antidepressive Agents; Arginine; Cyclic GMP; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Immobility Response, Tonic; Male; Memantine; Mice; Nitric Oxide; Nitric Oxide Donors; Nitroarginine; Penicillamine; Piperazines; Purines; Sildenafil Citrate; Sulfones; Swimming

Topics: Animals; Atrophy; Cell Count; Cytoprotection; Disease Models, Animal; Excitatory Amino Acid Antagonists; Geniculate Bodies; Glaucoma; Immunoenzyme Techniques; Intraocular Pressure; Macaca fascicularis; Memantine; Nerve Degeneration; Nerve Fibers; Neurons; Optic Nerve Diseases; Parvalbumins

Topics: Alzheimer Disease; Animals; Antiparkinson Agents; Brain Edema; Disease Models, Animal; Excitatory Amino Acid Antagonists; Female; Hippocampus; Humans; Memantine; Memory; Memory Disorders; Neuroprotective Agents; Rats; Rats, Sprague-Dawley

Topics: Animals; Brain Infarction; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Intracranial Embolism; Male; Memantine; Rabbits; Time Factors

Topics: Amyloid beta-Peptides; Animals; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Hippocampus; Ibotenic Acid; Male; Maze Learning; Memantine; Memory; Memory Disorders; Neurons; Neuroprotective Agents; Peptide Fragments; Rats; Rats, Inbred F344; Receptors, N-Methyl-D-Aspartate

Topics: Animals; Apoptosis Regulatory Proteins; Calpain; Cell Death; Corpus Striatum; Disease Models, Animal; Down-Regulation; Excitatory Amino Acid Antagonists; Huntingtin Protein; Huntington Disease; Male; Memantine; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Neurotoxins; Nitro Compounds; Nuclear Proteins; Peptide Fragments; Propionates; Rats; Rats, Sprague-Dawley

Topics: Animals; Behavior, Animal; Cytoskeletal Proteins; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Gliosis; Inflammation Mediators; Lipopolysaccharides; Male; Memantine; Memory; Memory Disorders; Microglia; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroprotective Agents; Rats; Rats, Inbred F344; Receptors, N-Methyl-D-Aspartate

Topics: Animals; Caspase 3; CD11b Antigen; Celecoxib; Cerebral Hemorrhage; Collagenases; Disease Models, Animal; Drug Therapy, Combination; Functional Laterality; In Situ Nick-End Labeling; Male; Memantine; Neuroprotective Agents; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides

Topics: Animals; Brain Damage, Chronic; Cerebellum; Disease Models, Animal; Excitatory Amino Acid Antagonists; Glutamic Acid; Hippocampus; Hypoxia, Brain; Intralaminar Thalamic Nuclei; Male; Memantine; Myoclonus; Nerve Degeneration; Neurotoxins; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission

Topics: Animals; Axons; Cell Survival; Disease Models, Animal; Erythropoietin; Fluorescent Antibody Technique, Indirect; Glaucoma; Intraocular Pressure; Memantine; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Microscopy, Fluorescence; Neuroprotective Agents; Optic Nerve; Optic Nerve Diseases; Receptors, Erythropoietin; Recombinant Proteins; Retinal Ganglion Cells

Topics: Animals; Disease Models, Animal; Fibrinolytic Agents; Male; Memantine; Rats; Rats, Wistar; Statistics, Nonparametric; Stroke; Tissue Plasminogen Activator; Treatment Failure

Topics: Age Factors; Analysis of Variance; Animals; Behavior, Animal; Conditioning, Psychological; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Down Syndrome; Excitatory Amino Acid Antagonists; Fear; Learning; Male; Memantine; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Mice, Transgenic; Motor Activity

Topics: Adrenergic alpha-Antagonists; Amines; Amitriptyline; Analgesics; Animals; Clonidine; Cyclohexanecarboxylic Acids; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Injections, Intraperitoneal; Injections, Spinal; Male; Memantine; Mice; Mice, Inbred C57BL; Morphine; N-Methylaspartate; Pain; Peripheral Nervous System; Phenylephrine; Piperazines; Prostaglandin Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, N-Methyl-D-Aspartate; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Reproducibility of Results; Spinal Cord; Spinal Nerves; Time Factors

Topics: Analysis of Variance; Animals; Cell Death; Disease Models, Animal; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Intraocular Pressure; Male; Memantine; Ocular Hypertension; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Retinal Ganglion Cells; Stilbamidines; Time Factors

Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Dopamine; Excitatory Amino Acid Antagonists; Homovanillic Acid; Humans; Macaca mulatta; Memantine; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Simian Acquired Immunodeficiency Syndrome; Up-Regulation; Viral Load

Topics: Alzheimer Disease; Animals; Antiparkinson Agents; Central Nervous System Stimulants; Cholinergic Fibers; Cognition Disorders; Disease Models, Animal; Female; Hippocampus; Maze Learning; Memantine; Mice; Nerve Degeneration; Receptors, N-Methyl-D-Aspartate; Space Perception; Time Factors

Topics: Animals; Brain Edema; Brain Ischemia; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Female; Functional Laterality; Hematoma, Subdural, Acute; Memantine; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric

Topics: Animals; Behavior, Animal; Biogenic Monoamines; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Memantine; Neuronal Plasticity; Neurotransmitter Uptake Inhibitors; Pemoline; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate; Self-Injurious Behavior

Topics: Alzheimer Disease; Animals; Axons; Behavior, Animal; Brain; Conditioning, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fear; Genotype; Memantine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Electron, Transmission; Neuroprotective Agents; Neurotoxins; Plaque, Amyloid; Synapses; Wallerian Degeneration

Topics: Animals; Disease Models, Animal; Hyperalgesia; Male; Memantine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Time Factors

Topics: Ammonia; Animals; Body Water; Brain; Disease Models, Animal; Electroencephalography; Glutamic Acid; Hepatic Encephalopathy; Intracranial Pressure; Ischemia; Liver; Male; Memantine; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate

Topics: Animals; Cell Count; Chromatography, High Pressure Liquid; Disease Models, Animal; Excitatory Amino Acid Antagonists; Glutamic Acid; Glycine; Intraocular Pressure; Ischemia; Male; Memantine; N-Methylaspartate; Ocular Hypertension; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells; Retinal Vessels; Vitreous Body

Topics: Alcohol Drinking; Alcoholism; Animals; Disease Models, Animal; Drinking; Eating; Ethanol; Excitatory Amino Acid Antagonists; Male; Memantine; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Self Administration

Topics: Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Evoked Potentials, Motor; Excitatory Amino Acid Antagonists; Memantine; Motor Neurons; Rabbits; Random Allocation; Receptors, N-Methyl-D-Aspartate; Spinal Cord; Spinal Cord Injuries; Statistics, Nonparametric; Time Factors

Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Chronic Disease; Disease Models, Animal; Humans; Memantine; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Secondary Prevention; Taurine

Topics: Animals; Animals, Newborn; Brain; Brain Ischemia; Cerebrovascular Disorders; Disease Models, Animal; Infarction; Light; Magnetic Resonance Imaging; Memantine; Neuroprotective Agents; Random Allocation; Rats; Rats, Long-Evans; Thrombosis

Topics: Anesthetics, Dissociative; Animals; Blood-Brain Barrier; Body Temperature; Disease Models, Animal; Esophagus; Evoked Potentials, Motor; Excitatory Amino Acid Antagonists; Infusions, Intravenous; Ketamine; Memantine; Neuroprotective Agents; Rabbits; Rectum; Spinal Cord; Spinal Cord Ischemia; Time Factors

Topics: Animals; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glaucoma; Male; Memantine; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate

Topics: Adrenergic alpha-Agonists; Animals; Apoptosis; Brimonidine Tartrate; Clinical Trials as Topic; Disease Models, Animal; Dopamine Agents; Eye Diseases; Forecasting; Glaucoma; Humans; Memantine; Neuroprotective Agents; Optic Neuritis; Quinoxalines; Retinal Diseases; Visual Fields

Topics: Adrenergic Agents; Animals; Anxiety; Apomorphine; Avoidance Learning; Disease Models, Animal; Dopamine; Dopamine Agents; GABA Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Hypothalamus, Middle; Male; Memantine; Microinjections; Neurotransmitter Agents; Phenylephrine; Picrotoxin; Rats; Serotonin; Sulpiride; Yohimbine

Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Apoptosis; Betaxolol; Brain-Derived Neurotrophic Factor; Brimonidine Tartrate; Calcium Channel Blockers; Disease Models, Animal; Dopamine Agents; Glaucoma; Glaucoma, Open-Angle; Haplorhini; Humans; Memantine; Neuroprotective Agents; Nimodipine; Nitric Oxide Synthase; Quinoxalines; Receptors, N-Methyl-D-Aspartate